Skip to main content
European Commission logo

Health & life sciences

Add to pdf basket
©mi_viri #455657879 | source: stock.adobe.com
Identifying telltale markers for personalised lung cancer treatment
T cell therapies are specifically tuned to a patient’s individual tumour, but choosing the right marker is key. A new method for identifying neoantigens in non-small cell lung cancer opens the door to improved treatments. The EU-funded CANVAS project set up a joint pilot study to further the work.
Add to pdf basket
©ake1150 #230925043 | source: stock.adobe.com
Inside the lab reshaping transplant research in Türkiye
Türkiye’s organ transplant programme ranks among the most active in the world, but until recently its research lagged behind its clinical achievements. The EU-funded TIREX project is changing that, strengthening the science that powers the country’s clinical success.
Add to pdf basket
©Gorodenkoff #236237463 | source: stock.adobe.com
The future of medical imaging: seeing the invisible with 4D-PET
Imagine peering into the human brain and observing its activity. Or guiding a surgeon’s hand in real time as they target cancerous tissue in the body. The EU-funded 4D-PET project offers enhanced medical imaging to transform how we diagnose and treat illness.
Add to pdf basket
©peterschreiber.media #1321145438 | source: stock.adobe.com
Investigating the mysteries of sleep
Sleep is one of biology’s most universal – and perplexing – phenomena. Why do animals need sleep, a state that seemingly leaves them vulnerable and unproductive? The EU-funded SleepSynapses project offered new insights to better understand sleep’s fundamental purpose.
Add to pdf basket
©meeboonstudio #582908876 | source: stock.adobe.com
How tiny microstructures in our organs hold big clues to our health
Every year, over 150 000 Europeans die as a result of liver disease. The EU-funded project LSO developed pioneering techniques to map the microstructure of the liver and other organs. The results provide new insights into liver regeneration, malaria treatment, insulin production and more.
Add to pdf basket
©A_B_C #212116643 | source: stock.adobe.com
Boosting citizen engagement in clean air campaigns
Air pollution is usually worse in urban centres, though residents are often less aware of its potential harm. The EU-funded CompAir project gave citizens the knowledge and tools needed to monitor and tackle air pollution – a solution that is particularly helpful for lower socio-economic groups throughout Europe.
Add to pdf basket
© Bamphen #1410063991 | source: stock.adobe.com
The Serbian lab using scorpion venom to fight cancer
The EU-funded NANOFACTS project helped transform Serbia’s BioSense Institute (BIOS) from a leader in agricultural sensing to a powerhouse for innovative cancer diagnostics and therapies. This project is part of the EU Mission on Cancer, which seeks to improve the lives of over 3 million people by 2030 through prevention, treatment and support for cancer patients and their families, enabling them to live longer and healthier lives.
Add to pdf basket
©Moopingz #894718772 | source: stock.adobe.com
Drawing a direct line between cellular acidic resistance and cancer treatment
Cancer is one of the leading causes of death in the EU. Researchers in the EU-funded Survive project examined how cells adapt to acidic conditions – a trait that can allow tumours to grow. Their findings highlight new ways to identify aggressive cancers, and point to potential new treatments to regulate acid resistance.
Add to pdf basket
©Oleksandr #1133071815 | source: stock.adobe.com
Making AI accessible for life science research
Analysing biological imagery such as microscope slides can be labour-intensive, especially as not all researchers know how best to automate this with AI. The EU-funded AI4LIFE project provides access to AI technologies, making models and AI-ready data sets open and accessible to everyone. This means researchers can spend more time interpreting data, accelerating scientific discovery.
Add to pdf basket
©mahamad #1060908735 | source: stock.adobe.com
Mirror image proteins could hold the key to new Parkinson’s treatments
The steady and debilitating progression of Parkinson’s is thought to be driven by the gradual accumulation of misfolded proteins in the brain. The EU-funded SYN-CHARGE project made the surprising discovery that these problem proteins may be targeted by peptide chains made from mirror image amino acids. The work lays the foundation for potential new therapies for several neurodegenerative diseases.

PDF Basket

No article selected
Convert to PDF Empty basket

Filter stories